U.S. Markets closed

ImmunoClin Corporation (IMCL)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.15930.0000 (0.0000%)
At close: 3:22PM EDT
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue1/31/20142/28/20131/31/2013
Total Revenue-182.621182.621
Cost of Revenue---
Gross Profit-182.621182.621
Operating Expenses
Research Development98.27693.12493.124
Selling General and Administrative12,676.052232.174232.174
Non Recurring---
Others208.1451.5081.508
Total Operating Expenses---
Operating Income or Loss-12,982.473-144.185-144.185
Income from Continuing Operations
Total Other Income/Expenses Net2.24575.79475.794
Earnings Before Interest and Taxes-12,980.228-68.391-68.391
Interest Expense0.0890.0470.047
Income Before Tax-12,980.317-68.438-68.438
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-12,980.317-68.438-68.438
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-12,980.317-68.438-68.438
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-12,980.317-68.438-68.438